OTCMKTS:MRVFF

Nuvo Pharmaceuticals Earnings Date, Estimates, & History

$0.62

0.00 (0.00%)

(As of 05/20/2022 12:00 AM ET)

Add

Compare

Today's Range: $0.62
▼
$0.62
50-Day Range: $0.62
▼
$1.25
52-Week Range: $0.62
▼
$1.41

Volume: N/A
Average Volume: 801 shs
Market Capitalization: $7.09 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: 1.32

Earnings Per Share Revenue

Nuvo Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Nuvo Pharmaceuticals Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

MRVFF Earnings Information

Nuvo Pharmaceuticals last announced its quarterly earnings results on March 28th, 2022. The reported ($0.18) earnings per share for the quarter. The firm had revenue of $14.05 million for the quarter. Nuvo Pharmaceuticals has generated ($1.56) earnings per share over the last year (($1.56) diluted earnings per share).

Nuvo Pharmaceuticals (OTCMKTS:MRVFF) Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
3/28/2022	Q4 2021		($0.18)	($0.18)	$0.03		$14.05 million
11/15/2021	Q3 2021		($0.27)	($0.27)	$0.70		$13.49 million
8/9/2021	Q2 2021		($0.07)	($0.07)	($0.22)		$16.11 million
5/17/2021	Q1 2021		($0.02)	($0.02)	$1.21		$11.39 million
3/8/2021	Q4 2020		$0.04	+$0.04	$0.04		$13.26 million
11/16/2020	Q3 2020		$0.07	+$0.07	$0.33		$12.46 million
11/16/2020	Q3 2020	$0.13	$0.09	($0.04)	$0.43	$16.40 million	$16.60 million
8/10/2020	Q2 2020		($0.12)	($0.12)	($0.12)		$11.20 million
8/10/2020	Q2 2020		($0.17)	($0.17)	($0.17)	$14.70 million	$15.53 million
5/11/2020	Q1 2020		$0.12	+$0.12	$0.12		$18.16 million

5/11/2020	Q1 2020		$0.16	+$0.16	$0.16		$24.36 million
2/25/2020	Q4 2019		$0.23	+$0.23	$0.23		$14.85 million
2/25/2020	Q4 2019	($0.05)	$0.30	+$0.35	$0.30	$16.20 million	$19.59 million
10/31/2019	Q3 2019		$0.01	+$0.01	($0.06)		$14.26 million
10/31/2019	Q3 2019	($0.03)	$0.01	+$0.04	($0.08)	$16.10 million	$18.82 million
8/14/2019	Q2 2019		($0.54)	($0.54)	($0.69)		$12.40 million
8/14/2019	Q2 2019	($0.28)	($0.72)	($0.44)	($0.92)	$15.30 million	$16.58 million
5/14/2019	Q1 2019		($0.15)	($0.15)	$0.19		$10.94 million
5/14/2019	Q1 2019	($0.21)	($0.19)	+$0.02	$0.27	$13.00 million	$14.55 million
3/29/2019	Q4 2018		($0.28)	($0.28)	($0.25)		$3.49 million
3/29/2019	Q4 2018		($0.37)	($0.37)	($0.33)	$4.50 million	$4.61 million
11/8/2018	Q3 2018		$0.03	+$0.03	$0.22		$3.89 million
11/8/2018	Q3 2018	$0.03	$0.04	+$0.01	$0.29	$4.90 million	$5.09 million
8/2/2018	Q2 2018		$0.07	+$0.07	$0.07		$4.55 million
8/2/2018	Q2 2018	$0.01	$0.09	+$0.08	$0.09		$5.88 million
5/10/2018	Q1 2018		$0.02	+$0.02	$0.05		$3.51 million
5/10/2018	Q1 2018	$0.02	$0.02		$0.05		$4.43 million
3/23/2018	Q4 2017		($0.02)	($0.02)	($0.02)		$3.53 million
3/23/2018	Q4 2017	$0.15	($0.02)	($0.17)	($0.02)		$4.49 million
11/1/2017	Q3 2017		($0.02)	($0.02)	($0.02)		$2.36 million
11/1/2017	Q3 2017	$0.07	($0.02)	($0.09)	($0.02)		$2.96 million
8/9/2017	Q2 2017		($0.02)	($0.02)	($0.02)		$2.31 million
8/9/2017	Q2 2017	($0.07)	($0.02)	+$0.05	($0.02)		$3.10 million
5/10/2017	Q1 2017		$0.14	+$0.14	$0.14		$5.27 million
5/10/2017	Q1 2017	$0.17	$0.19	+$0.02	$0.19		$6.98 million
3/1/2017	Q4 2016		$0.11	+$0.11	$0.11		$4.18 million
3/1/2017	Q4 2016	$0.24	$0.12	($0.12)	$0.12		$5.57 million
11/10/2016	Q3 2016		$0.07	+$0.07	$0.07		$4.23 million
11/10/2016	Q3 2016	$0.22	$0.10	($0.12)	$0.10		$5.52 million
8/10/2016	Q2 2016		$0.16	+$0.16	$0.16		$6.29 million
8/10/2016	Q2 2016		$0.21	+$0.21	$0.21		$8.11 million
5/11/2016	Q1 2016		$0.11	+$0.11	$0.30		$5.72 million
5/11/2016	Q1 2016		$0.15	+$0.15	$0.41		$7.84 million
2/17/2016	Q4 2015		$0.02	+$0.02	$0.02		$5.88 million
2/17/2016	Q4 2015	($0.38)	$0.03	+$0.41	$0.03	$4.70 million	$7.84 million
11/10/2015	Q3 2015		($0.08)	($0.08)	($0.08)		$4.37 million
11/10/2015	Q3 2015	($0.40)	($0.11)	+$0.29	($0.11)	$3.80 million	$5.72 million
8/5/2015	Q2 2015		($0.45)	($0.45)	($0.45)		$2.64 million
8/5/2015	Q2 2015	($0.10)	($0.55)	($0.45)	($0.55)	$3.80 million	$3.25 million
5/12/2015	Q1 2015		($0.02)	($0.02)	($0.02)		$3.67 million
5/12/2015	Q1 2015	($0.39)	($0.03)	+$0.36	($0.03)	$2.90 million	$4.50 million
2/19/2015	Q4 2014		($0.49)	($0.49)	($0.49)		$2.99 million
2/19/2015	Q4 2014	($0.30)	($0.56)	($0.26)	($0.56)	$3.40 million	$3.40 million
11/10/2014	Q3 2014		($0.23)	($0.23)	($4.87)		$2.76 million
11/10/2014	Q3 2014	($0.28)	($0.25)	+$0.03	($5.30)	$3.40 million	$3.01 million
7/30/2014	Q2 2014		($0.21)	($0.21)	($0.21)		$3.54 million
7/30/2014	Q2 2014	($0.25)	($0.23)	+$0.02	($0.23)	$3.30 million	$3.86 million
4/30/2014	Q1 2014		($0.28)	($0.28)	($0.28)		$2.51 million
4/30/2014	Q1 2014		($0.31)	($0.31)	($0.31)		$2.76 million
2/20/2014	Q4 2013		($0.21)	($0.21)	($0.21)		$1.29 million
2/20/2014	Q4 2013	($0.38)	($0.22)	+$0.16	($0.22)	$2.80 million	$1.33 million
10/30/2013	Q3 2013		$0.37	+$0.37	$1.07		$0.80 million
10/30/2013	Q3 2013	$0.36	$0.39	+$0.03	$1.12	$8.48 million	$0.83 million
7/31/2013	Q2 2013		($0.24)	($0.24)	($0.24)		$1.63 million
7/31/2013	Q2 2013	($0.16)	($0.25)	($0.09)	($0.25)	$4.01 million	$1.67 million
5/1/2013	Q1 2013		($0.38)	($0.38)	($0.38)		$0.60 million
5/1/2013	Q1 2013		($24.68)	($24.68)	($24.68)	$3.73 million	$0.60 million
10/31/2012	Q3 2012		$0.65	+$0.65	$0.65
8/1/2012	Q2 2012		$0.39	+$0.39	$0.39
5/2/2012	Q1 2012		($0.26)	($0.26)	($0.26)
2/29/2012	Q4 2011		($0.32)	($0.32)	($0.32)
11/2/2011	Q3 2011		($0.19)	($0.19)	($0.19)
8/10/2011	Q2 2011		($0.19)	($0.19)	($0.38)
5/26/2011	Q1 2011		($0.65)	($0.65)	($0.65)
2/24/2011	Q4 2010		($0.26)	($0.26)	($0.26)
10/27/2010	Q3 2010		($0.32)	($0.32)	($0.32)
7/29/2010	Q2 2010		($0.45)	($0.45)	($0.45)
4/29/2010	Q1 2010		($0.52)	($0.52)	($0.52)
2/19/2010	Q4 2009		$3.90	+$3.90	$3.90
10/28/2009	Q3 2009		($0.45)	($0.45)	($0.45)
8/7/2009	Q2 2009		($0.32)	($0.32)	($0.32)
4/30/2009	Q1 2009		($0.58)	($0.58)	($0.58)
10/30/2008	Q3 2008		($0.65)	($0.65)	($0.65)
7/31/2008	Q2 2008		($0.58)	($0.58)	($0.58)
5/1/2008	Q1 2008		($0.52)	($0.52)	($0.52)

(Earnings results data provided by Zacks Investment Research)

Nuvo Pharmaceuticals (OTCMKTS:MRVFF) Earnings Frequently Asked Questions

When did Nuvo Pharmaceuticals announce their last quarterly earnings?: Nuvo Pharmaceuticals (OTCMKTS:MRVFF) last announced its quarterly earning data on Monday, March 28, 2022. Learn more on MRVFF's earnings history.

How much revenue does Nuvo Pharmaceuticals generate each year?: Nuvo Pharmaceuticals (OTCMKTS:MRVFF) has a recorded annual revenue of $54.98 million.
How much profit does Nuvo Pharmaceuticals generate each year?: Nuvo Pharmaceuticals (OTCMKTS:MRVFF) has a recorded net income of -$25.69 million. MRVFF has generated -$1.56 earnings per share over the last four quarters.

This page was last updated on 5/21/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources